You are here

  • Home
  • Archive
  • Volume 12, Issue 12
  • Mitigating Infectious morbidity and Growth deficits in HIV-exposed uninfected infanTs with human Milk Oligosaccharide (MIGH-T MO): a randomised trial protocol

Citation Tools

Article menu

Download PDFPDF

HIV/AIDS
Protocol
Mitigating Infectious morbidity and Growth deficits in HIV-exposed uninfected infanTs with human Milk Oligosaccharide (MIGH-T MO): a randomised trial protocol

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Shivakoti R, Slogrove AL, Laughton B, et al
Mitigating Infectious morbidity and Growth deficits in HIV-exposed uninfected infanTs with human Milk Oligosaccharide (MIGH-T MO): a randomised trial protocol
BMJ Open 2022;12:e069116. doi: 10.1136/bmjopen-2022-069116